[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001235616A1 - Immunostimulatory oligonucleotides - Google Patents

Immunostimulatory oligonucleotides

Info

Publication number
AU2001235616A1
AU2001235616A1 AU2001235616A AU3561601A AU2001235616A1 AU 2001235616 A1 AU2001235616 A1 AU 2001235616A1 AU 2001235616 A AU2001235616 A AU 2001235616A AU 3561601 A AU3561601 A AU 3561601A AU 2001235616 A1 AU2001235616 A1 AU 2001235616A1
Authority
AU
Australia
Prior art keywords
immunostimulatory oligonucleotides
immunostimulatory
oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001235616A
Other languages
English (en)
Inventor
Monique Bachy
Regis Sodoyer
Emanuelle Trannoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur SA filed Critical Aventis Pasteur SA
Publication of AU2001235616A1 publication Critical patent/AU2001235616A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/18—Type of nucleic acid acting by a non-sequence specific mechanism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001235616A 2000-02-18 2001-02-07 Immunostimulatory oligonucleotides Abandoned AU2001235616A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0002057 2000-02-18
FR0002057A FR2805265B1 (fr) 2000-02-18 2000-02-18 Oligonucleotides immunostimulants
PCT/FR2001/000349 WO2001062909A1 (fr) 2000-02-18 2001-02-07 Oligonucleotides immunostimulants

Publications (1)

Publication Number Publication Date
AU2001235616A1 true AU2001235616A1 (en) 2001-09-03

Family

ID=8847156

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001235616A Abandoned AU2001235616A1 (en) 2000-02-18 2001-02-07 Immunostimulatory oligonucleotides

Country Status (3)

Country Link
AU (1) AU2001235616A1 (fr)
FR (1) FR2805265B1 (fr)
WO (1) WO2001062909A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
AU761899B2 (en) 1998-05-22 2003-06-12 Ottawa Health Research Institute Methods and products for inducing mucosal immunity
EP1150710B1 (fr) 1999-02-17 2010-04-21 Csl Limited Complexes immunogenes et methodes y relatives
WO2001022972A2 (fr) 1999-09-25 2001-04-05 University Of Iowa Research Foundation Acides nucleiques immunostimulateurs
NZ552377A (en) 2001-08-17 2008-08-29 Coley Pharm Gmbh Combination motif immune stimulatory oligonucleotides with improved activity
CA2388049A1 (fr) 2002-05-30 2003-11-30 Immunotech S.A. Oligonucleotides immunostimulateurs et utilisations connexes
EP1578954A4 (fr) 2002-12-11 2010-08-11 Coley Pharm Group Inc Acides nucleiques 5'cpg et leurs methodes d'utilisation
WO2011109833A2 (fr) 2010-03-05 2011-09-09 President And Fellows Of Harvard College Compositions de cellules dendritiques induites et utilisations associées

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1167377B2 (fr) * 1994-07-15 2012-08-08 University of Iowa Research Foundation Oliogonucléotides immunomodulateurs
AU7589398A (en) * 1997-05-19 1998-12-11 Merck & Co., Inc. Oligonucleotide adjuvant

Also Published As

Publication number Publication date
FR2805265A1 (fr) 2001-08-24
FR2805265B1 (fr) 2002-04-12
WO2001062909A1 (fr) 2001-08-30

Similar Documents

Publication Publication Date Title
HUP0301229A3 (en) Immunostimulatory oligodeoxynucleotides
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2002211620A1 (en) Autoanastomosis
AU2001220246A1 (en) Neckphone
AU2001258349A1 (en) Bisacylguanidine
AU2001296577A1 (en) Chlorophyllases
AU2001279754A1 (en) Indoloquinazolinones
AU2002211128A1 (en) Step-bike
AU2001290931A1 (en) Ski-snowboard
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001244687A1 (en) Micro-array
AU2001258924A1 (en) Microsatellite-aflp
AU2001293852A1 (en) Sulfonylguanidine
AU2002245107A1 (en) Improved biochip
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001240791A1 (en) Sequence
AU2001235616A1 (en) Immunostimulatory oligonucleotides
AU2001240103A1 (en) Reproduction-specific genes
AU2001281921A1 (en) Bdellosomes
AU2001246864A1 (en) Hypotensors
AU2001291876A1 (en) Triazolo-epothilones